The Board of Directors of Aurobindo Pharma Limited has authorized a buyback plan on July 18, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,336 INR | -2.53% |
|
+1.40% | +23.28% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.28% | 961.06Cr | |
+55.35% | 82TCr | |
+32.32% | 60TCr | |
-0.10% | 38TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+16.26% | 25TCr | |
+14.06% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited authorizes a Buyback Plan.